Assessment of oleoylethanolamide supplementattion in the prevention and treatment of obesity
Not Applicable
- Conditions
- obesity.Obesity due to excess caloriesE66.0
- Registration Number
- IRCT201607132017N30
- Lead Sponsor
- Vice-Chancellor for Research of Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
healthy obese subjects in both genders (males and females)
Ages between 18 to 59 years
body mass index 30-40 kg/m2
Exclusion Criteria
having kidney problems, liver failure, heart failure, rheumatic diseases and gastrointestinal diseases
smoking
Breastfeeding and pregnancy and menopause
Taking probiotic and prebiotic supplements, vitamin, minerals, omega-3 and weight-reducing drugs and antibiotics during past one month
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Gene expression of PPAR-a. Timepoint: before and after supplementation. Method of measurement: Real time-PCR.;Inflammatory biomarkers (IL-6? TNF-a ? hs-CRP). Timepoint: before and after supplemenation. Method of measurement: IL-6 and TNF-a using ELISA, hs-CRP using spectrometry method.;The abundance of Akkermansia muciniphila bacteria in stool samples. Timepoint: before and after supplemenation. Method of measurement: colony count.;Total antioxidant capacity. Timepoint: before and after supplemenation. Method of measurement: using ELISA method.;Lipid profiles and fasting blood glucose. Timepoint: before and after supplementation. Method of measurement: Using ELISA method.;Dietary intake. Timepoint: before and after supplemenation. Method of measurement: Three days food record questionnaire.
- Secondary Outcome Measures
Name Time Method Anthropometric measurements. Timepoint: at baseline and at the end of intervention. Method of measurement: Using a stadiometertape and tape in accordance with the standards.;Appetite status. Timepoint: at baseline and at the end of study. Method of measurement: Visual Analouge Scale questionnaire.